2020
DOI: 10.1016/j.bmc.2019.115256
|View full text |Cite
|
Sign up to set email alerts
|

Identification of Mycobacterium tuberculosis CtpF as a target for designing new antituberculous compounds

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
10
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 8 publications
(11 citation statements)
references
References 47 publications
1
10
0
Order By: Relevance
“…Modeled structure of CtpF using Ca 2+ -bound SERCA1a in E1 confirmation (PDB code 1SU4) as the template is shown in Figure S1. Model of CtpF in an alternate confirmation E2 (with inhibitor Cyclopiazonic Acid bound) was reported recently (Santos et al, 2020). Although our results, in general, are in broad agreement with theirs, there are a few subtle differences.…”
Section: Ctpf Is a Bonafide Calcium Atpasesupporting
confidence: 91%
See 3 more Smart Citations
“…Modeled structure of CtpF using Ca 2+ -bound SERCA1a in E1 confirmation (PDB code 1SU4) as the template is shown in Figure S1. Model of CtpF in an alternate confirmation E2 (with inhibitor Cyclopiazonic Acid bound) was reported recently (Santos et al, 2020). Although our results, in general, are in broad agreement with theirs, there are a few subtle differences.…”
Section: Ctpf Is a Bonafide Calcium Atpasesupporting
confidence: 91%
“…Notably, the observation that CtpF is not essential in vitro but provides a survival advantage to the intracellular Mtb, reaffirms its potential as a drug target. The modeling studies presented by us and others (Santos et al, 2020) provide some insights in this direction. Similar to SERCA ATPase (Olesen et al, 2007;Di Marino et al, 2015), CtpF may also exist in a number of conformational states including the calcium bound and unbound forms.…”
Section: Discussionmentioning
confidence: 78%
See 2 more Smart Citations
“…CPA is an example of blocking signaling cascade in bacteria so that its extracellular transportation and tough bacterial infection could be inhibited. The recent literature had delivered essential findings about mycobacterial ctpF that include molecular docking and virtual screening that lead to the identification of effective inhibitor of the ATPase activity of the protein [44,45,46].…”
Section: Mycobacterial P-type Atpasesmentioning
confidence: 99%